The WHO's urgent call for DRC neighbors to mobilize against the Bundibugyo Ebola strain reveals systemic delays in detection that echo the 2018-2020 DRC outbreak, where observational data from 3,400+ cases showed conflict zones amplifying transmission by 40% due to disrupted surveillance (WHO situation reports, not RCTs). Unlike the Zaire strain's rVSV-ZEBOV vaccine—which reduced mortality in a 2019 ring-vaccination trial of 7,700 participants with no major conflicts of interest—the current Bundibugyo variant lacks approved countermeasures, a gap the original MedicalXpress coverage underplays by focusing solely on Tedros's statements without noting Africa's CDC Saturday alert on 10 at-risk nations. This outbreak's rapid spread, with 10 confirmed and 220 suspected deaths since May 15, connects to patterns in the 2007 Uganda Bundibugyo event (observational cohort of 116 cases), where distrust in insecure eastern DRC provinces now compounds the issue, risking Uganda's single confirmed fatality escalating regionally. Peer-reviewed analyses in The Lancet Infectious Diseases highlight that observational studies on prior outbreaks consistently miss early cross-border seeding due to small sample sizes under 500 in conflict settings, a flaw evident here as operations lag the epidemic. Genuine analysis shows mainstream outlets often delay emphasis until surges, yet data from the 2014-2016 West Africa epidemic (RCTs on supportive care, n=500+) prove early action cuts R0 by over 50%.